Review Article
Volume 17 Issue 4 - 2021
Diabetic Kidney Disease: Epidemiology, Risks, Manifestations, Diagnosis, and Management
Rasha Khaled Sendy1*, Faisal Musaad I Alhoshan2, Marwah Yahya Almuzaini2, Enaam Mohammed Shubily3, Areej Abdulaziz Alwaheed4, Hasan Haider Aljalooud5, Ali Hassan Almasskin5, Nouh Ahmed Al-Taweel5, Radhi Essa Alali5, Abdulmohsen Jaber Al-Abood5 and Ali Hadi Yahya Madkhali6
1King Fahad General Hospital, Jeddah, Saudi Arabia
2Ibn Sina National College for Medical Studies, Jeddah, Saudi Arabia
3Armed Forces Hospital, Jazan, Saudi Arabia
4Qatif Central Hospital, Qatif, Saudi Arabia
5Vision College of Medicine, Vision Colleges, Riyadh, Saudi Arabia
6Comprehensive Clinics Specialized for the Security Forces, Jeddah, Saudi Arabia
*Corresponding Author: Rasha Khaled Sendy, Medical Registrar, King Fahad General Hospital, Jeddah, Saudi Arabia.
Received: March 06, 2021; Published: March 29, 2021


Introduction: Diabetes is the most common cause of chronic kidney disease (CKD) and end-stage kidney disease (ESKD) in the world. Both type 1 and type 2 diabetic patients are commonly to have Chronic kidney disease (CKD), which defined as three months history of a glomerular filtration rate (GFR) reduction and/or an increased albumin excretion in the urine. The prevalence of diabetes in the United States has raised from 6 to 10 per cent over the last 20 years. While the percentage of diabetic patients CKD has maintained.

Aim of the Work: An overview of diabetic kidney disease (DKA), also known as diabetic nephropathy, will be presented in this paper.

Methodology: This paper is a nonsystematic review of medical literature regarding diabetic kidney disease. The literature search was conducted by using PubMed database and google scholar search engine.

Conclusion: Diabetic kidney disease and CKD are more common in women, African American, and Latino. Obesity is considered an essential risk factor for type 2 diabetes and coexists with type 1 diabetes. Persistently raised levels of albuminuria and/or persistent (eGFR) reduction are considered the most frequent clinical finding. Majority of patients’ presentation are asymptomatic for that, regular and routine checkup is the method of detection. If non-diabetic kidney disease is suspected, a kidney biopsy should have conducted. Management of DKD include general measures such as controlling blood pressure, glycemic control, and lifestyle modification. Angiotensin inhibition is the drug of choice in cases with severe albuminuria.

Keywords: Diabetic Kidney Disease; Diabetic Nephropathy; Diabetes Mellitus Chronic Complications


  1. Olivarius Nde F., et al. “Epidemiology of renal involvement in newly-diagnosed middle-aged and elderly diabetic patients. Cross-sectional data from the population-based study “Diabetes Care in General Practice”, Denmark. Di”. Diabetologia 10 (1993): 1007-1016.
  2. Mogensen CE., et al. “The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy”. Diabetes2 (1983): 64.
  3. Krolewski AS., et al. “Early progressive renal decline precedes the onset of microalbuminuria and its progression to macroalbuminuria”. Diabetes Care 37 (2014): 226.
  4. Krolewski AS. “Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes”. Diabetes Care 38 (2015): 954.
  5. Afkarian M., et al. “Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014”. The Journal of the American Medical Association 316 (2016): 602.
  6. Afkarian M., et al. “Kidney disease and increased mortality risk in type 2 diabetes”. Journal of the American Society of Nephrology 24 (2013): 302.
  7. Mayer-Davis EJ., et al. “Incidence Trends of Type 1 and Type 2 Diabetes among Youths, 2002-2012”. The New England Journal of Medicine 376 (2017): 1419.
  8. Dabelea D., et al. “Association of Type 1 Diabetes vs Type 2 Diabetes Diagnosed During Childhood and Adolescence With Complications During Teenage Years and Young Adulthood”. The Journal of the American Medical Association 317 (2017): 825.
  9. Kahkoska AR., et al. “The early natural history of albuminuria in young adults with youth-onset type 1 and type 2 diabetes”. Journal of Diabetes and its Complications 32 (2018): 1160.
  10. Centers for Disease Control and Prevention. Chronic Kidney Disease Surveillance System - United States (2018).
  11. Burrows NR., et al. “Incidence of treatment for end-stage renal disease among individuals with diabetes in the U.S. continues to decline”. Diabetes Care 33 (2010): 73.
  12. United States Renal Data System. USRDS 2018 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. National Institutes of Health, editor, National Institutes of Health, National Institute of Diabetes (2018).
  13. Tsai WC., et al. “Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis”. Medicine (Baltimore) 95 (2016): e3013.
  14. Sharma K., et al. “Adiponectin regulates albuminuria and podocyte function in mice”. Journal of Clinical Investigation 118 (2008): 1645.
  15. Liao D., et al. “Cigarette smoking as a risk factor for diabetic nephropathy: A systematic review and meta-analysis of prospective cohort studies”. PLoS One 14 (2019): e0210213.
  16. Ku E., et al. “Association Between Blood Pressure and Adverse Renal Events in Type 1 Diabetes”. Diabetes Care 39 (2016): 2218.
  17. Guan M., et al. “Genome-wide association study identifies novel loci for type 2 diabetes-attributed end-stage kidney disease in African Americans”. Human Genomics 13 (2019): 21.
  18. Kruzel-Davila E., et al. “APOL1 nephropathy: from gene to mechanisms of kidney injury”. Nephrology Dialysis Transplantation 31 (2016): 349.
  19. American Diabetes Association. 11. Microvascular Complications and Foot Care: Standards of Medical Care in Diabetes-2019”. Diabetes Care 42 (2019): S124.
  20. “KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease”. The American Journal of Kidney Diseases 49 (2007): S12.
  21. O’Neill WM Jr., et al. “Hematuria and red cell casts in typical diabetic nephropathy”. The American Journal of Medicine 74 (1983): 389.
  22. Jiang S., et al. “Accuracy of hematuria for predicting non-diabetic renal disease in patients with diabetes and kidney disease: A systematic review and meta-analysis”. Diabetes Research and Clinical Practice 143 (2018): 288.
  23. Ali MK., et al. “Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988-2014”. The Lancet Diabetes and Endocrinology 6 (2018): 392.
  24. Fiorentino M., et al. “Renal biopsy in patients with diabetes: a pooled meta-analysis of 48 studies”. Nephrology Dialysis Transplantation 32 (2017): 97.
  25. Gæde P., et al. “Effect of a multifactorial intervention on mortality in type 2 diabetes”. The New England Journal of Medicine 358 (2008): 580.
  26. An Y., et al. “Renal histologic changes and the outcome in patients with diabetic nephropathy”. Nephrology Dialysis Transplantation 30 (2015): 257.
  27. Mazzucco G., et al. “Different patterns of renal damage in type 2 diabetes mellitus: a multicentric study on 393 biopsies”. The American Journal of Kidney Diseases 39 (2002): 713.
  28. Jamerson K., et al. “Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients”. The New England Journal of Medicine 359 (2008): 2417.
  29. DCCT/EDIC Research Group de Boer IH., et al. “Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes”. The New England Journal of Medicine 365 (2011): 2366.
  30. Flynn C and Bakris GL. “Noninsulin glucose-lowering agents for the treatment of patients on dialysis”. Nature Reviews Nephrology 9 (2013): 147.
  31. Barnett AH., et al. “Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy”. The New England Journal of Medicine 351 (2004): 1952.
  32. Dekkers CCJ., et al. “Effects of the sodium-glucose co-transporter 2 inhibitor dapagliflozin in patients with type 2 diabetes and Stages 3b-4 chronic kidney disease”. Nephrology Dialysis Transplantation 33 (2018): 2005.
  33. Salah HM., et al. “Effect of sodium-glucose cotransporter 2 inhibitors on cardiovascular and kidney outcomes-Systematic review and meta-analysis of randomized placebo-controlled trials”. American Heart Journal 232 (2021): 10.
  34. Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease”. Kidney International 98 (2020): S1.
  35. Agarwal R., et al. “Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine”. European Heart Journal 42 (2021): 152.
Citation: Rasha Khaled Sendy., et al. “Diabetic Kidney Disease: Epidemiology, Risks, Manifestations, Diagnosis, and Management”. EC Microbiology 17.4 (2021): 09-17.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

May Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the May issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 24, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to